Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-β1/Smad Signalling Pathway.
Ma H, Duan X, Zhang R, Li H, Guo Y, Tian Y, Huang M, Chen G, Wang Z, Li L.
Ma H, et al. Among authors: li h, li l.
Evid Based Complement Alternat Med. 2022 Jul 15;2022:8661288. doi: 10.1155/2022/8661288. eCollection 2022.
Evid Based Complement Alternat Med. 2022.
PMID: 35873644
Free PMC article.
Retracted.